<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Dermatitis allergic &#8211; European Clinical Trials Information Network</title>
	<atom:link href="https://clinicaltrials.eu/meddra_pt/dermatitis-allergic/feed/" rel="self" type="application/rss+xml" />
	<link>https://clinicaltrials.eu</link>
	<description>Bridging Patients with Clinical Trials</description>
	<lastBuildDate>Tue, 02 Jun 2026 12:26:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png</url>
	<title>Dermatitis allergic &#8211; European Clinical Trials Information Network</title>
	<link>https://clinicaltrials.eu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Study on the Safety and Effectiveness of Metal Panel Allergens for Diagnosing Allergic Contact Dermatitis and Eczema in Patients</title>
		<link>https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-metal-panel-allergens-for-diagnosing-allergic-contact-dermatitis-and-eczema-in-patients/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Wed, 29 Apr 2026 15:05:48 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-metal-panel-allergens-for-diagnosing-allergic-contact-dermatitis-and-eczema-in-patients/</guid>

					<description><![CDATA[This clinical trial is focused on studying the safety and effectiveness of a group of substances known as Metal Panel Allergens. These substances are used to test for allergic contact dermatitis, a type of skin reaction that occurs when the skin comes into contact with certain metals. The study will use a special patch test [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>This clinical trial is focused on studying the safety and effectiveness of a group of substances known as <i>Metal Panel Allergens</i>. These substances are used to test for <i>allergic contact dermatitis</i>, a type of skin reaction that occurs when the skin comes into contact with certain metals. The study will use a special patch test to apply these allergens to the skin. The allergens being tested include <i>Nickel Sulfate</i>, <i>Copper Sulfate</i>, <i>Tin Chloride</i>, <i>Manganese Chloride</i>, <i>Zinc Chloride</i>, <i>Cobalt Chloride</i>, <i>Gold Sodium Thiosulfate</i>, <i>Sodium Tetrachloropalladate</i>, <i>Vanadium Oxide Sulfate</i>, <i>Ammonium Titanium Oxalate</i>, and <i>Potassium Dichromate</i>. These substances are applied to the skin using a device called the <i>allergEAZE Patch Test Chamber</i>, which helps to deliver the allergens in a controlled manner.</p>
<p>The purpose of the study is to evaluate how well these allergens can diagnose allergic contact dermatitis and to ensure they are safe to use. Participants will have the allergens applied to their skin in the form of patches, which will remain in place for a short period. The study will monitor any skin reactions that occur, which can help determine if a person is allergic to any of the metals tested. The study will also compare the results of this patch test method with a reference method to see how well they agree.</p>
<p>The trial will take place over a period of time, with participants being monitored for any reactions to the allergens. The study aims to provide valuable information on the safety and performance of these metal allergens in diagnosing allergic contact dermatitis. This information could help improve the way allergies to metals are diagnosed and managed in the future.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Study on the Safety and Effectiveness of Metal Panel Allergens for Patients with Allergic Contact Dermatitis</title>
		<link>https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-metal-panel-allergens-for-patients-with-allergic-contact-dermatitis/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Wed, 29 Apr 2026 15:05:31 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-metal-panel-allergens-for-patients-with-allergic-contact-dermatitis/</guid>

					<description><![CDATA[This clinical trial is focused on studying allergic contact dermatitis, a skin condition that occurs when the skin reacts to certain substances, often metals. The study will use a variety of substances applied to the skin in the form of patches to see if they cause a reaction. These substances include copper sulfate, stannous chloride, [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>This clinical trial is focused on studying <i>allergic contact dermatitis</i>, a skin condition that occurs when the skin reacts to certain substances, often metals. The study will use a variety of substances applied to the skin in the form of patches to see if they cause a reaction. These substances include <i>copper sulfate</i>, <i>stannous chloride</i>, <i>zinc chloride</i>, <i>cobalt chloride</i>, <i>gold sodium thiosulfate</i>, <i>sodium tetrachloropalladate</i>, <i>vanadium oxide sulfate</i>, <i>ammonium titanium oxalate</i>, <i>nickel sulfate</i>, <i>manganese chloride</i>, and <i>potassium dichromate</i>. The purpose of the study is to evaluate the safety and effectiveness of these substances in diagnosing allergic contact dermatitis.</p>
<p>Participants in the study will have patches containing these substances applied to their skin. The patches will remain in place for a short period, and the skin will be observed for any reactions. This process helps determine if a person is allergic to any of the metals tested. The study will also use a <i>placebo</i> patch for comparison. The trial aims to ensure that the patches are safe and perform well in identifying allergies.</p>
<p>The study will take place over a few days, with participants visiting the clinic for patch application and follow-up checks. The results will help improve understanding of how these metal allergens affect people with suspected metal allergies and contribute to better diagnostic methods for <i>allergic contact dermatitis</i>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
